Malignant neoplasms of prostate ICD11 code: 2D32.Z
Oral > Solid: 5 mg ; 25 mg
EML status history
Adolescents and adults
Medicines within the same pharmacological class can be used
Patents have expired in most jurisdictions
Read more about patents.
Summary of evidence and Expert Committee recommendations
The listing for prednisolone on the EML was extended to include the new indication of metastatic castration-resistant prostate cancer. Refer to the 2019 recommendation for abiraterone for more information.